H. El-serag and K. Rudolph, Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis, Gastroenterology, vol.132, issue.7, pp.2557-2576, 2007.
DOI : 10.1053/j.gastro.2007.04.061

J. [. Ferlay, F. Bray, D. Forman, C. Mathers, and D. Parkin, Globocan 2008 v2.0, Cancer incidence and Mortality Worldwide: IARC CancerBase No10 [Internet], International Agency for Research on Cancer. Available, 2010.

H. El-serag, J. Marrero, L. Rudolph, and K. Reddy, Diagnosis and Treatment of Hepatocellular Carcinoma, Gastroenterology, vol.134, issue.6, 2008.
DOI : 10.1053/j.gastro.2008.02.090

J. Massagué, TGF?? Signaling: Receptors, Transducers, and Mad Proteins, Cell, vol.85, issue.7, pp.947-95081296, 1996.
DOI : 10.1016/S0092-8674(00)81296-9

J. Massagué, TGF?? in Cancer, Cell, vol.134, issue.2, pp.215-230, 2008.
DOI : 10.1016/j.cell.2008.07.001

M. Yakicier, M. Irmak, A. Romano, M. Kew, and M. Ozturk, Smad2 and Smad4 gene mutations in hepatocellular carcinoma, Oncogene, vol.18, issue.34, pp.4879-4883, 1999.
DOI : 10.1038/sj.onc.1202866

L. Mishra, T. Banker, J. Murray, S. Byers, and A. Thenappan, Liver stem cells and hepatocellular carcinoma, Hepatology, vol.10, issue.1, pp.318-329, 2009.
DOI : 10.1002/hep.22704

Y. Tang, V. Katuri, A. Dillner, B. Mishra, and C. Deng, Disruption of transforming growth factor-beta signaling in ELF beta-spectrindeficient mice, Science, vol.299, 2003.

A. Fischer, B. Herrera, M. Mikula, V. Proell, and E. Fuchs, Integration of Ras subeffector signaling in TGF-?? mediated late stage hepatocarcinogenesis, Carcinogenesis, vol.26, issue.5, pp.931-942, 2005.
DOI : 10.1093/carcin/bgi043

Y. Park, K. Chae, B. Oh, J. Choi, and K. Choi, Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta, Hepatogastroenterology, vol.51, pp.396-400, 2004.

B. Bauche, B. Delvoux, A. Gressner, A. Tannapfel, and S. Dooley, Abrogation of TGF signaling in hepatocellular carcinoma by overexpression of antagonistic Smad7, Hepatology, vol.34, p.665

H. Nagata, E. Hatano, M. Tada, M. Murata, and K. Kitamura, Inhibition of c-Jun NH2-terminal kinase switches Smad3 signaling from oncogenesis to tumor-suppression in rat hepatocellular carcinoma Factors of transforming growth factor beta signalling are coregulated in human hepatocellular carcinoma, Hepatology Virchows Arch, vol.49, issue.445, pp.1944-1953, 2004.

S. Dennler, S. Itoh, D. Vivien, P. Ten-dijke, and S. Huet, Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene, EMBO J, vol.17, p.9606191, 1998.

M. Fujii, K. Takeda, T. Imamura, H. Aoki, and T. Sampath, Roles of Bone Morphogenetic Protein Type I Receptors and Smad Proteins in Osteoblast and Chondroblast Differentiation, Molecular Biology of the Cell, vol.10, issue.11, 1999.
DOI : 10.1091/mbc.10.11.3801

M. Stopa, D. Anhuf, L. Terstegen, P. Gatsios, and A. Gressner, Participation of Smad2, Smad3, and Smad4 in Transforming Growth Factor ?? (TGF-??)-induced Activation of Smad7: THE TGF-?? RESPONSE ELEMENT OF THE PROMOTER REQUIRES FUNCTIONAL Smad BINDING ELEMENT AND E-BOX SEQUENCES FOR TRANSCRIPTIONAL REGULATION, Journal of Biological Chemistry, vol.275, issue.38, pp.29308-29317, 2000.
DOI : 10.1074/jbc.M003282200

C. Coulouarn, V. Factor, and S. Thorgeirsson, Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer, Hepatology, vol.47, 2008.

K. Matsuzaki, Smad phosphoisoform signaling specificity: the right place at the right time, Carcinogenesis, vol.32, issue.11, pp.1578-1588, 2011.
DOI : 10.1093/carcin/bgr172

T. Saha, D. Vardhini, Y. Tang, V. Katuri, and W. Jogunoori, RING finger-dependent ubiquitination by PRAJA is dependent on TGF-?? and potentially defines the functional status of the tumor suppressor ELF, Oncogene, vol.8, issue.5, pp.693-705, 2006.
DOI : 10.1038/23293

S. Kim, K. Shetty, V. Katuri, K. Kitisin, and H. Baek, TGF-beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta-spectrin, ELF, Biochem Biophys Res Commun, vol.344, 2006.

L. Mishra, V. Katuri, and S. Evans, The role of PRAJA and ELF in TGF-?? signaling and gastric cancer, Cancer Biology & Therapy, vol.4, issue.7, pp.694-699, 2005.
DOI : 10.4161/cbt.4.7.2015

K. Kitisin, N. Ganesan, Y. Tang, W. Jogunoori, and E. Volpe, Disruption of transforming growth factor-beta signaling through betaspectrin ELF leads to hepatocellular cancer through cyclin D1 activation, Oncogene, vol.26, p.17546056, 2007.

D. Samanta and P. Datta, Alterations in the Smad pathway in human cancers, Frontiers in Bioscience, vol.17, issue.1, pp.1281-1293, 2012.
DOI : 10.2741/3986

D. Lee, Y. Chung, J. Kim, Y. Lee, and M. Jang, Transforming Growth Factor Beta 1 Overexpression Is Closely Related to Invasiveness of Hepatocellular Carcinoma, Oncology, vol.82, issue.1, pp.11-18, 2012.
DOI : 10.1159/000335605

T. Mamiya, K. Yamazaki, Y. Masugi, T. Mori, and K. Effendi, Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis, Lab Invest, vol.90, p.20531292, 2010.

K. Yamazaki, Y. Masugi, and M. Sakamoto, Molecular Pathogenesis of Hepatocellular Carcinoma: Altering Transforming Growth Factor-?? Signaling in Hepatocarcinogenesis, Digestive Diseases, vol.29, issue.3, 2011.
DOI : 10.1159/000327560

Y. Chen, A. Huang, P. Cheng, S. Yang, and L. Lin, Overexpression of Smad proteins, especially Smad7, in oral epithelial dysplasias, Clinical Oral Investigations, vol.29, issue.3, pp.921-953, 2012.
DOI : 10.1007/s00784-012-0756-7

S. Dowdy, A. Mariani, M. Reinholz, G. Keeney, and T. Spelsberg, Overexpression of the TGF-?? antagonist Smad7 in endometrial cancer, Gynecologic Oncology, vol.96, issue.2, pp.368-373, 2005.
DOI : 10.1016/j.ygyno.2004.10.006

H. Zhang, I. Ozaki, T. Mizuta, H. Hamajima, and T. Yasutake, Involvement of programmed cell death 4 in transforming growth factor- beta1-induced apoptosis in human hepatocellular carcinoma, Oncogene, vol.25, p.16682950, 2006.

Y. [. Yamamura, S. Bergelson, and H. Lodish, Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-??-dependent Apoptosis, Journal of Biological Chemistry, vol.275, issue.46, pp.36295-36302, 2000.
DOI : 10.1074/jbc.M006023200

W. Ju, A. Ogawa, J. Heyer, D. Nierhof, and L. Yu, Deletion of Smad2 in Mouse Liver Reveals Novel Functions in Hepatocyte Growth and Differentiation, Molecular and Cellular Biology, vol.26, issue.2, pp.654-667, 2006.
DOI : 10.1128/MCB.26.2.654-667.2006

Y. Hua, S. Li, J. Lai, L. Liang, and B. Peng, [Changes in TGF-beta1/Smads signaling pathway in rats with chemical hepatocarcinogenesis], Nan Fang Yi Ke Da Xue Xue Bao, vol.28, pp.1848-1852, 2008.

A. Mazzocca, E. Fransvea, F. Dituri, L. Lupo, and S. Antonaci, Down-regulation of connective tissue growth factor by inhibition of transforming growth factor ?? blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma, Hepatology, vol.15, issue.2, pp.523-534, 2010.
DOI : 10.1002/hep.23285

G. Giannelli, C. Bergamini, E. Fransvea, F. Marinosci, and V. Quaranta, Human Hepatocellular Carcinoma (HCC) Cells Require Both ??3??1 Integrin and Matrix Metalloproteinases Activity for Migration and Invasion, Laboratory Investigation, vol.65, issue.4, pp.613-627, 2001.
DOI : 10.1083/jcb.146.6.1375

A. Majumdar, S. Curley, X. Wu, P. Brown, and J. Hwang, Hepatic stem cells and transforming growth factor ?? in hepatocellular carcinoma, Nature Reviews Gastroenterology & Hepatology, vol.25, issue.9, pp.530-538
DOI : 10.1038/nrgastro.2012.114

S. Dooley, J. Hamzavi, L. Ciuclan, P. Godoy, and I. Ilkavets, Hepatocyte-Specific Smad7 Expression Attenuates TGF-?????Mediated Fibrogenesis and Protects Against Liver Damage, Gastroenterology, vol.135, issue.2, pp.642-659, 2008.
DOI : 10.1053/j.gastro.2008.04.038

P. Godoy, J. Hengstler, I. Ilkavets, C. Meyer, and A. Bachmann, Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis, Hepatology, vol.49, 2009.

S. Zellmer, W. Schmidt-heck, P. Godoy, H. Weng, and C. Meyer, Transcription factors ETF, E2F, and SP-1 are involved in cytokine-independent proliferation of murine hepatocytes, Hepatology, vol.331, issue.6, pp.2127-2136, 2010.
DOI : 10.1002/hep.23930

C. Meyer, P. Godoy, A. Bachmann, Y. Liu, and D. Barzan, Distinct role of endocytosis for Smad and non-Smad TGF-beta signalling regulation in hepatocytes, J Hepatol, vol.55, p.21184784, 2011.

Y. Chen, P. Wong, L. Sjeklocha, C. Steer, and M. Sahin, Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture, Hepatology, vol.31, issue.Suppl 1, 2012.
DOI : 10.1002/hep.24712

A. Wells, Y. Chao, J. Grahovac, Q. Wu, and D. Lauffenburger, Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis, Frontiers in Bioscience, vol.16, issue.1, pp.815-837, 2011.
DOI : 10.2741/3722

L. Caja, P. Sancho, E. Bertran, and I. Fabregat, Dissecting the effect of targeting the epidermal growth factor receptor on TGF-??-induced-apoptosis in human hepatocellular carcinoma cells, Journal of Hepatology, vol.55, issue.2, pp.351-358, 2011.
DOI : 10.1016/j.jhep.2010.10.041

L. Caja, P. Sancho, E. Bertran, D. Iglesias-serret, and J. Gil, Overactivation of the MEK/ERK Pathway in Liver Tumor Cells Confers Resistance to TGF-??-Induced Cell Death through Impairing Up-regulation of the NADPH Oxidase NOX4, Cancer Research, vol.69, issue.19, pp.7595-7602, 2009.
DOI : 10.1158/0008-5472.CAN-09-1482

K. Matsuzaki, M. Murata, K. Yoshida, G. Sekimoto, and Y. Uemura, Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor ?? signaling, promoting cirrhosis and hepatocellular carcinoma, Hepatology, vol.420, issue.1, pp.48-57, 2007.
DOI : 10.1002/hep.21672

M. Murata, K. Matsuzaki, K. Yoshida, G. Sekimoto, and Y. Tahashi, Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-?? signaling from tumor suppression to oncogenesis in early chronic hepatitis B, Hepatology, vol.281, issue.Suppl, pp.1203-1217, 2009.
DOI : 10.1002/hep.22765

T. Watanabe, T. Morizane, K. Tsuchimoto, Y. Inagaki, and Y. Munakata, Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma, International Journal of Cancer, vol.44, issue.2, pp.141-146, 1983.
DOI : 10.1002/ijc.2910320202

H. Saito, T. Morizane, T. Watanabe, T. Kagawa, and M. Iwabuchi, Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection, Cancer, vol.32, issue.5, pp.1054-106010, 1989.
DOI : 10.1002/1097-0142(19890901)64:5<1054::AID-CNCR2820640516>3.0.CO;2-X

M. Breinig, E. Caldas-lopes, B. Goeppert, M. Malz, and R. Rieker, Targeting heat shock protein 90 with non-quinone inhibitors: A novel chemotherapeutic approach in human hepatocellular carcinoma, Hepatology, vol.353, issue.1, pp.102-112, 2009.
DOI : 10.1002/hep.22912